Archive for the ‘Lung Cancer’ Category
Thursday, April 3rd, 2008
Researchers at Johns Hopkins, as part of a large, multi-institutional study, have found one gene variant that is linked to an increased risk of lung cancer. The study will be published in the April 3 issue of Nature Genetics.The research team collected DNA from 1,154 smokers who have lung cancer ...
Posted in Lung Cancer | No Comments »
Thursday, April 3rd, 2008
A genetic variant has been identified which makes smokers more likely to become addicted to nicotine, have an increased lung cancer risk as well as a higher risk of peripheral arterial disease. The study was supported by NIDA (National Institute on Drug Abuse), part of the NIH (National Institutes ...
Posted in Lung Cancer | No Comments »
Wednesday, April 2nd, 2008
Researchers from Boston University School of Medicine have developed a new "clinicogenomic model" to accurately test for lung cancer. The model combines a specific gene expression for lung cancer as well as clinical risk factors. These findings currently appear on-line in the journal Cancer Prevention Research.Lung cancer is the leading ...
Posted in Lung Cancer | No Comments »
Thursday, March 27th, 2008
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced that approximately 90 percent of CyberKnife centers worldwide are now treating lung cancer with the CyberKnife® Robotic Radiosurgery System*. The number of lung cancer patients is growing significantly as well, with more than 5,000 individuals receiving CyberKnife ...
Posted in Lung Cancer | No Comments »
Wednesday, March 26th, 2008
Exposure to levels of radon gas typically found in 90 percent of American homes appears to reduce the risk of developing lung cancer by as much as 60 percent, according to a study published in the March 2008 issue of the journal Health Physics. The finding differs significantly from the ...
Posted in Lung Cancer | No Comments »
Friday, March 21st, 2008
A small RNA molecule, known as let-7 microRNA (miRNA), substantially reduced cancer growth in multiple mouse models of lung cancer, according to work by researchers at Yale University and Asuragen, Inc., published in the journal Cell Cycle. Cancer afflicts 1.5 million people a year in the United States alone, and ...
Posted in Lung Cancer | No Comments »
Thursday, March 20th, 2008
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, announced that preliminary data from a Phase 1 trial of an oral formulation of picoplatin in patients with solid tumors will be presented at the 2008 American Association for Cancer Research meeting to be held from April ...
Posted in Lung Cancer | No Comments »
Wednesday, March 19th, 2008
A new report from the Society for Cardiothoracic Surgery in Great Britain & Ireland (published by Dendrite Clinical Systems), has for the first time recorded the variations in activity and surgical approaches between thoracic surgical units in the United Kingdom and Ireland. Presented at the recent Annual Meeting of the ...
Posted in Lung Cancer | No Comments »
Wednesday, March 19th, 2008
BioNumerik Pharmaceuticals, Inc. ("BioNumerik") and ASKA Pharmaceutical Co., Ltd. ("ASKA") announced the results of a Phase III clinical trial of Tavocept(TM) in patients with advanced non-small cell lung cancer. Tavocept is an investigational new drug with potential for oncology and non-oncology indications that was originated and developed by ...
Posted in Lung Cancer | No Comments »
Tuesday, March 18th, 2008
National Lung Cancer Partnership, in partnership with the LUNGevity Foundation, is pleased to announce the winners of their third annual research grant competition.The research grants, each $100,000, were created to advance research in basic lung cancer biology, risk assessment, prevention, detection, and response to treatment. "With the support of Genentech ...
Posted in Lung Cancer | No Comments »